Africa Asia Middle East عربي Français Português free subscription IRIN Site Map RSS find PlusNews on facebook follow PlusNews on twitter
Global HIV/AIDS news and analysis
Advanced search
 Saturday 05 June 2010
Weekly reports 
In-Depth reports 
Country profiles 
Fact files 
Most read 
Print report Bookmark and Share
UGANDA: It takes money to get universal access to treatment

Photo: Nic McPhee/Flickr
Is universal access the responsibility of government rather than donors?
KAMPALA, 1 December 2009 (PlusNews) - As donors tighten their belts in the global recession, health experts in Uganda worry that the national antiretroviral (ARV) programme, which is almost entirely dependent on foreign aid, will be unable to keep providing the life-prolonging drugs.

Uganda is only able to provide ARVs to 57 percent of the 240,000 people who require them, and the number is growing. "We require up to 70 million US dollars every year to treat our targeted patients," said Zainabu Akol, head of the HIV/AIDS programme in the ministry of health.

"[In 2008] we could only secure 20 million from the Global Fund [to Fight AIDS, Tuberculosis and Malaria] for close to 90,000 patients' treatment, and another 20 million from PEPFAR [the US President's Emergency Plan for AIDS Relief] for another 100,000 patients; the situation remains one of shortages."

Funding shrinking

PEPFAR recently announced that funding for ARV programmes would not be increased. "We now have a flat budget for Uganda, since the first phase of PEPFAR ended in 2008. This fiscal year we are going to commit $285 million for our programmes of sustainability, prevention, care and treatment," said Lynne McDermott, PEPFAR's communication officer in the capital, Kampala.

Some local partners too would not be adding to the number of patients they were treating. "The US has been the main funder of HIV/AIDS in Uganda, so what is going to happen to new infected persons?" asked Chris Baryomunsi, a member of parliament on the house select committee on HIV and related matters.

In 2008 the government allocated more than $30 million to purchase ARVs, but the money was diverted to pay health ministry staff. An ARV manufacturing plant, opened in 2008 to cut the costs of AIDS drugs, has so far not made any significant contribution to ARV provision.

The health ministry made an emergency appeal to the Global Fund for $8.9 million to purchase ARVs for three months as an advance on $70 million awarded in Round Seven of its grants, but the world body could only offer $4.25 million in June, which Akol described as "a drop in the ocean".

The Global Fund was forced to cut funding by 10 percent in 2008. A recent World Bank report advised nations heavily reliant on foreign aid to prepare for any impending cash and drug shortages by implementing early warning systems, and work to avoid treatment interruptions as far as possible.

ARV programme in danger

Health minister Stephen Mallinga said it would be virtually impossible to expand ARV programmes. "We would rather sustain those that have started the treatment ... because the ramifications ... [of not accessing drugs] are grave, including resistance to drugs and therefore a requirement to change the combination ... which will lead to an increase in our treatment bill, which we cannot afford," he told IRIN/PlusNews.

Countdown to Universal Access
 The universal access hit parade
 A long walk to universal access
 Low uptake of ARVs hampering universal access
 Inching towards universal access of PMTCT services
 The bumpy road to universal access
 On course to achieve treatment-access targets
 Government empowers nurses to boost ARV treatment
 No simple formula for universal access
 Universal access - the race is on!
AIDS activists are concerned that funding woes will make it impossible for Uganda to achieve universal access to treatment, or giving drugs to at least 80 percent of people who need them.

"Ways and means within the recession should be found. The alternative to not providing universal access is much more expensive and dangerous - we will not be able to control the epidemic," said Peter Mugyenyi, AIDS activist and founder of Uganda's Joint Clinical Research Centre.

"When drugs are unavailable and patients start to share them, they begin to get side effects and have to switch [regimens], but second-line drugs are double the price of first-line drugs, and the third line are ultra-modern drugs which are unaffordable," Mugyenyi said. "If we are having problems with the first line, what about the second and third line?"

Ministry officials said the government could not afford treatment for everyone needing it, but many activists feel that universal access is the responsibility of government rather than donors, and if the government fulfilled its role as the primary healthcare provider, ARV rollout would be much more sustainable than with donor aid.

Government must own ARV rollout

"It is wrong to say that government cannot afford to ... [provide ARVs]; the main problem is that we have not had our priorities right, and the commitment is not there," said Samuel Kibanga, coordinator of the National Forum of People Living with HIV/AIDS Networks in Uganda (NAFOPHANU). He and other activists have suggested imposing an HIV/AIDS tax, with the proceeds going into a national trust fund for purchasing ARVs.

"Ninety-five percent of treatment funding is from donors, which is very unsustainable. Health expenditure should at least be 15 percent of the total national budget, but currently it is less than 10 percent, while the component for ARV treatment is too miserable," Kibanga pointed out.

"For the public good, and to save as many lives as possible, we should provide universal access," Mugyenyi said. "Otherwise, you create a much more serious problem."


Theme(s): (PLUSNEWS) Care/Treatment - PlusNews, (PLUSNEWS) Economy, (PLUSNEWS) Governance, (PLUSNEWS) HIV/AIDS (PlusNews)


[This report does not necessarily reflect the views of the United Nations]
Print report Bookmark and Share
FREE Subscriptions
Your e-mail address:

Submit your request
 More on Uganda
UGANDA: When do we tell children they are HIV positive?
GLOBAL: PMTCT could be key to cutting child mortality
GLOBAL: ARVs for prevention? Proceed with caution, say researchers
GLOBAL: Pregnancy increases men's HIV risk
GLOBAL: IRIN/PlusNews Weekly Issue 485, 14 May 2010
 More on Care/Treatment - PlusNews
SOUTH AFRICA: Drug resistance, alcohol and money
UGANDA: When do we tell children they are HIV positive?
SOUTH AFRICA: Activists call for integrated HIV/TB services
SOUTH AFRICA: TB response fails children
SOUTH AFRICA: Musa Njoko, "What made me really mad was the failure to diagnose my TB in good time"
 Most Read 
SOUTH AFRICA: Sports stars urge men to "do the right thing"
UGANDA: When do we tell children they are HIV positive?
SOUTH AFRICA: TB response fails children
SOUTH AFRICA: World Cup HIV prevention plans fall short
SOUTH AFRICA: Activists call for integrated HIV/TB services
Back | Home page

Services:  Africa | Asia | Middle East | Film & TV | Photo | Radio | Live news map | E-mail subscription
Feedback · IRIN Terms & Conditions · Really Simple Syndication News Feeds · About PlusNews · Jobs · Donors

Copyright © IRIN 2010
This material comes to you via IRIN, the humanitarian news and analysis service of the UN Office for the Coordination of Humanitarian Affairs. The opinions expressed do not necessarily reflect those of the United Nations or its Member States. Republication is subject to terms and conditions as set out in the IRIN copyright page.